Cargando…
B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171678/ http://dx.doi.org/10.1097/01.HS9.0000936100.98079.1e |
| _version_ | 1785039473787011072 |
|---|---|
| author | van de Donk, N. Minnema, M.C. van der Holt, B. Schjesvold, F. Wu, K.L. Capra, A. Broyl, A. Roeloffzen, W.W.H. Gadisseur, A.P.A. Pietrantuono, G. Pour, L. van der Velden, V. Lund, T. Offidani, M. Grasso, M. Giaccone, L. Cavo, M. Silkjaer, T. Caers, J. Zweegman, S. Hajek, R. Benjamin, R. Vangsted, A. Boccadoro, M. Gay, F. Sonneveld, P. Musto, P. |
| author_facet | van de Donk, N. Minnema, M.C. van der Holt, B. Schjesvold, F. Wu, K.L. Capra, A. Broyl, A. Roeloffzen, W.W.H. Gadisseur, A.P.A. Pietrantuono, G. Pour, L. van der Velden, V. Lund, T. Offidani, M. Grasso, M. Giaccone, L. Cavo, M. Silkjaer, T. Caers, J. Zweegman, S. Hajek, R. Benjamin, R. Vangsted, A. Boccadoro, M. Gay, F. Sonneveld, P. Musto, P. |
| author_sort | van de Donk, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171678 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101716782023-05-11 B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS van de Donk, N. Minnema, M.C. van der Holt, B. Schjesvold, F. Wu, K.L. Capra, A. Broyl, A. Roeloffzen, W.W.H. Gadisseur, A.P.A. Pietrantuono, G. Pour, L. van der Velden, V. Lund, T. Offidani, M. Grasso, M. Giaccone, L. Cavo, M. Silkjaer, T. Caers, J. Zweegman, S. Hajek, R. Benjamin, R. Vangsted, A. Boccadoro, M. Gay, F. Sonneveld, P. Musto, P. Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171678/ http://dx.doi.org/10.1097/01.HS9.0000936100.98079.1e Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Best Abstracts - Oral Presentations van de Donk, N. Minnema, M.C. van der Holt, B. Schjesvold, F. Wu, K.L. Capra, A. Broyl, A. Roeloffzen, W.W.H. Gadisseur, A.P.A. Pietrantuono, G. Pour, L. van der Velden, V. Lund, T. Offidani, M. Grasso, M. Giaccone, L. Cavo, M. Silkjaer, T. Caers, J. Zweegman, S. Hajek, R. Benjamin, R. Vangsted, A. Boccadoro, M. Gay, F. Sonneveld, P. Musto, P. B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS |
| title | B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS |
| title_full | B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS |
| title_fullStr | B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS |
| title_full_unstemmed | B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS |
| title_short | B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS |
| title_sort | b02 carfilzomib and lenalidomide-based therapy for the treatment of primary plasma cell leukemia: results of the final analysis of the prospective phase 2 emn12/hovon-129 study for patients aged 18-65 years |
| topic | Best Abstracts - Oral Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171678/ http://dx.doi.org/10.1097/01.HS9.0000936100.98079.1e |
| work_keys_str_mv | AT vandedonkn b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT minnemamc b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT vanderholtb b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT schjesvoldf b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT wukl b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT capraa b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT broyla b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT roeloffzenwwh b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT gadisseurapa b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT pietrantuonog b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT pourl b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT vanderveldenv b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT lundt b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT offidanim b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT grassom b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT giacconel b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT cavom b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT silkjaert b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT caersj b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT zweegmans b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT hajekr b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT benjaminr b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT vangsteda b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT boccadorom b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT gayf b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT sonneveldp b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years AT mustop b02carfilzomibandlenalidomidebasedtherapyforthetreatmentofprimaryplasmacellleukemiaresultsofthefinalanalysisoftheprospectivephase2emn12hovon129studyforpatientsaged1865years |